CervoMed Inc. (CRVO) NASDAQ

8.61

+0.105(+1.24%)

Updated at July 31 11:52AM

Currency In USD

Valuation

Market Cap18.89M
Enterprise Value9.89M
P/E Ratio-3.96
PEG Ratio0.47
Price/Sales Ratio22.49
Price/Book Ratio2.14
Enterprise/Revenue19.3
Enterprise/EBITDA-3.03

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-5.68
Operating Margin-6.37

Management Effectiveness

Return On Assets-0.48
Return On Equity-0.44

Income Statement

Revenue9.74M
Revenue/Share0.38
Gross Profit-9.06M
EBITDA-18.23M
Net Income-16.29M
Diluted EPS-2.02

Balance Sheet

Total Cash35.24M
Total Cash/Share4.05
Total Debt0
Total Debt/Equity0
Current Ratio20.73
Book Value Per Share3.98

Price History

52-Week Change-34.62
52-Week High20.63
52-Week Low1.8
Moving Average 50 Days7.45
Moving Average 200 Days7.19

Statistics

Average Volume402,488
Shares Outstanding8.7M
% Held by Institutions26.24

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor2:3
Last Split DateAugust 17, 2023